- Oral presentation
- Open Access
Serum inhibitory and bactericidal titers in the clinical management of bacterial infections
BMC Infectious Diseases volume 14, Article number: O20 (2014)
The clinical management of bacterial infection computes factors related to bacteria (e.g., resistance profile ), antibiotics (e.g., activity spectrum, distribution volume, etc.), host characteristics (e.g., vascularization of the infected tissue, effectiveness of host defenses, etc.), as well as pharmacokinetic (PK) parameters . The serum inhibitory (SIT) and bactericidal titers (SBT) are laboratory tests that simulate the interactions between antibiotics and bacteria in the human body milieu.
In the Emergency Laboratory of the Adults 2 Clinical Ward of the National Institute for Infectious Diseases "Prof. Dr. Matei Balş", we consistently perform SIT and SBT in complicated cases of bacterial infections. We have retrospectively collected and analyzed data from such tests performed between 2012 and 2014 and correlated the results with the patient’s overall clinical evolution. We present the descriptive results.
We have analyzed 89 cases. The serum antibiotics tested were: linezolid (15 cases, 16.9%), carbapenems (12 cases, 13.5%) with (5 cases) and without (7 cases) colistin, aminopenicillins (10 cases, 11.2%), and in smaller percentages: oxacillin, tigecycline, fluoroquinolones, trimethoprim/sulfamethoxazole, glycopeptides, aminoglycosides, ceftaroline and other cephalosporins.
In most cases serum samples were collected at the time of peak PK, with the exception of three cases where the trough concentration was examined instead. The tested germs were mostly Staphylococcus spp. (51.7%), followed by Enterococcus spp. (14.6%), Streptococcus spp. (9%) and Gram-negative bacilli (24.7%) such as: E. coli, Klebsiella spp. and Pseudomonas spp. The strains had been isolated from blood cultures (49.4%), cutaneous wounds (23.6%), tracheal aspirate (13.5%) and urine samples (7.9%).
SIT ranged from 1/2 (12.4%) to 1/512 (5.6%), but only in 20 cases (22.4%) the titers were in the therapeutic comfort range of 1/64 to 1/512. SBT ranged from 0 (11.2%) to 1/256 (6.7%). SIT and SBT were equal and in the comfort range for 2 strains of wound Staphylococcus, 4 strains of blood culture Staphylococcus, and 3 strains of tracheal aspirate E. coli.
Interdisciplinary patient management and good collaboration with the bacteriology laboratory all contribute to establishing, maintaining and adapting targeted antimicrobial therapy.
Streinu-Cercel O: Expected sensitivity to antibiotics in bacterial infections. GERMS. 2013, 3: 7-10.11599/germs.2013.1030.
Kiang TK, Häfeli UO, Ensom MH: A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring. Clin Pharmacokinet. 2014, 53: 695-730. 10.1007/s40262-014-0152-3.
2) Carol Davila University of Medicine and Pharmacy, Young Researchers Projects Grant Competition, contract number 28.336/04.11.2013.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Berciu, I., Săndulescu, O., Streinu-Cercel, A. et al. Serum inhibitory and bactericidal titers in the clinical management of bacterial infections. BMC Infect Dis 14 (Suppl 7), O20 (2014). https://doi.org/10.1186/1471-2334-14-S7-O20